Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 800-181-3 | CAS number: 371756-75-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Key value for chemical safety assessment
Repeated dose toxicity: via oral route - systemic effects
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- 50
Additional information
Oral exposure: Reliable data have been obtained on repeated dose toxicity of three members of the category of derivatives of 4,4’-bis(1,3,5-triazinyl-2-yl)amino)stilbene-2,2’-disulfonic acid, each with one anilino and one alkyl amino moiety: EC 432-690-8, EC 476-900-6 and EC 416-640-2.
Dermal exposure: The test material is a highly polar salt with a poly-anion of high molecular weight. It is used exclusively in aqueous solutions and completely ionised. Therefore, a significant skin penetration (bioavailability) and adverse effects via dermal exposure are not expected. Additionally the test material did show adverse systemic effects only after high doses (500-750 mg/kg bw) by oral gavage for prolonged periods and a structurally closely related substance did not cause skin irritation or sensitisation. Thus, no adverse effects are expected after dermal exposure with low bio-availability and no in vivo study (animal use) is justified.
Inhalation: The test material is produced and handled in industry exclusively in aqueous solutions. There are no spraying operations. Thus neither exposure nor risks are expected via the inhalation route.
EC 432-690-8:
Subchronic toxicity after repeated oral exposure (gavage) was evaluated on
the basis of a 90 day study according to OECD Guideline 408 (Repeated
Dose 90-Day Oral Toxicity in Rodents) in rats (Sprague-Dawley;
male/female) with daily exposure.The
dose range was: 5 mg/kg bw/day (actual ingested), 50
mg/kg bw/day (actual ingested) and 750
mg/kg bw per day (reduced to 500 mg/kg bw/day on day 56 due to severe
effects).Parameters examined were: Mortality, clinical signs, FOB, body
weights, food consumption, clinical chemistry, haematology, necropsy,
histopathology
The broad and unspecific spectrum of findings in a large number of organs indicate an unspecific distribution of well being of the animals by the application of high doses of the substance over an extended period of time. The main targets most probably are liver and kidneys as these organs handle and excrete xenobiotic material. Most of the other changes can be interpreted as secondary effects of the reduced performance of these organs. As no effects were detected at the mid and low dose levels the effects in the high dose group are seen as an effect of metabolic overload of the rat organism. The NOAEL (90 d) is 50mg/kg bw.
EC 476-900-6:
Subacute toxicity after repeated oral exposure was evaluated on the basis of a 28-day (feeding) study according to OECD Guideline 407 (Repeated Dose 28-Day Oral Toxicity in Rodents) in rats (Wistar rats; male/female) with daily exposure of the test substance registered. Five animals per sex and dose were tested. The dose ranges tested were 0, 50, 200 and 1000 mg/kg bw/day (nominal in diet). Concentration, homogeneity and stability of test item in the feed were determined. The 28 day treatment resulted in no test item related deaths, no clear test item related clinical signs during daily or weekly observations, no test item related findings during functional observation battery, no differences in mean daily food consumption or mean bodyweights upon mean absolute or relative organ weights, no macroscopical and no microscopical findings. The target dose levels were largely attained. The missing of any adverse findings in the 28-day repeated dose (feeding) study performed with the test substance up to the highest dose tested (i.e. 1000 mg/kg bw/day) provides indication that the toxic potential after prolonged treatment is low.
EC 416-640-2:
Subacute toxicity after repeated oral exposure was
evaluated on the basis of a 28-day (feeding) study according to OECD
Guideline 407 (Repeated Dose 28-Day Oral Toxicity in Rodents) in rats
(Sprgue-Dawley; male/female) with daily exposure of the test substance
registered. Five animals per sex and dose were tested. The dose ranges
tested were 0, 15, 150 and 1000 mg/kg bw/day (nominal in diet). Oral
administration of the test material for a period of 28 consecutive days,
at dose levels up to 1000 mg/kg bw/day, resulted in treatment related
changes at dose levels of 150 and 1000 mg/kg bw/day. No such effects
were demonstrated in animals treated with 15 mg/kg bw/day and the NOEL
is, therefore, considered to be 15 mg/kg bw/day. The changes observed at
a dose level of 150 mg/kg bw/day were considered not to be indicative of
serious damage to the health of the animals
and not sufficient to warrant classification.
Justification for classification or non-classification
Dangerous Substance Directive (67/548/EEC)
The available studies are considered reliable and suitable for classification purposes under 67/548/EEC. As a result the category members are not considered to be classified for repeated toxicity under Directive 67/548/EEC, as amended for the 28th time in Directive 2001/59/EC.
Classification, Labelling, and Packaging Regulation (EC) No. 1272/2008
The available experimental test data are reliable and suitable for classification purposes under Regulation 1272/2008. As a result the category members are not considered to be classified for repeated toxicity under Regulation (EC) No. 1272/2008.Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.